nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Clenbuterol—NGF—epilepsy syndrome	0.0196	0.409	CrCbGaD
Bupranolol—Gemfibrozil—CYP2C19—epilepsy syndrome	0.00552	0.115	CrCbGaD
Bupranolol—Terbutaline—BCHE—epilepsy syndrome	0.0049	0.102	CrCbGaD
Bupranolol—Clenbuterol—TNF—epilepsy syndrome	0.0038	0.0793	CrCbGaD
Bupranolol—Timolol—CYP2C19—epilepsy syndrome	0.00379	0.079	CrCbGaD
Bupranolol—Timolol—CYP2D6—epilepsy syndrome	0.00281	0.0585	CrCbGaD
Bupranolol—Carteolol—CYP2D6—epilepsy syndrome	0.0025	0.0522	CrCbGaD
Bupranolol—Timolol—ABCB1—epilepsy syndrome	0.002	0.0418	CrCbGaD
Bupranolol—Nadolol—ABCB1—epilepsy syndrome	0.00159	0.0332	CrCbGaD
Bupranolol—Pindolol—CYP2D6—epilepsy syndrome	0.0014	0.0293	CrCbGaD
Bupranolol—ADRB2—Signaling by GPCR—CCR2—epilepsy syndrome	0.000246	0.000258	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—SST—epilepsy syndrome	0.000246	0.000258	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000245	0.000257	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PLAT—epilepsy syndrome	0.000244	0.000256	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000244	0.000256	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL2—epilepsy syndrome	0.000242	0.000254	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—POMC—epilepsy syndrome	0.000242	0.000254	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000241	0.000253	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GNAO1—epilepsy syndrome	0.000241	0.000253	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—OPRD1—epilepsy syndrome	0.000241	0.000253	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000238	0.00025	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000237	0.000248	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000237	0.000248	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL2—epilepsy syndrome	0.000236	0.000248	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000235	0.000247	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL12—epilepsy syndrome	0.000235	0.000247	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—OPRD1—epilepsy syndrome	0.000235	0.000247	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GNAO1—epilepsy syndrome	0.000235	0.000247	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—POMC—epilepsy syndrome	0.000235	0.000247	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000234	0.000246	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000233	0.000245	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000232	0.000244	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CNR1—epilepsy syndrome	0.000232	0.000244	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000231	0.000243	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000231	0.000243	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000231	0.000243	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—JUNB—epilepsy syndrome	0.000231	0.000243	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CNR1—epilepsy syndrome	0.000231	0.000243	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CHRM1—epilepsy syndrome	0.000231	0.000242	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDYN—epilepsy syndrome	0.000231	0.000242	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GRM1—epilepsy syndrome	0.000231	0.000242	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR7—epilepsy syndrome	0.000231	0.000242	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PLCB1—epilepsy syndrome	0.00023	0.000242	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CNR1—epilepsy syndrome	0.000227	0.000239	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR7—epilepsy syndrome	0.000227	0.000238	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000226	0.000238	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDYN—epilepsy syndrome	0.000226	0.000237	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CHRM1—epilepsy syndrome	0.000226	0.000237	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GRM1—epilepsy syndrome	0.000226	0.000237	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR7—epilepsy syndrome	0.000226	0.000237	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR7—epilepsy syndrome	0.000225	0.000237	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR7—epilepsy syndrome	0.000222	0.000233	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HBEGF—epilepsy syndrome	0.00022	0.000231	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HBEGF—epilepsy syndrome	0.000219	0.00023	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000217	0.000228	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GFAP—epilepsy syndrome	0.000217	0.000228	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GAL—epilepsy syndrome	0.000217	0.000228	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AKT3—epilepsy syndrome	0.000216	0.000227	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000215	0.000226	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AKT3—epilepsy syndrome	0.000215	0.000226	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CASP2—epilepsy syndrome	0.000214	0.000225	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CHRM3—epilepsy syndrome	0.000214	0.000225	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GRM5—epilepsy syndrome	0.000214	0.000225	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—POMC—epilepsy syndrome	0.000213	0.000224	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000212	0.000223	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GAL—epilepsy syndrome	0.000212	0.000223	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GFAP—epilepsy syndrome	0.000212	0.000223	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AKT3—epilepsy syndrome	0.000211	0.000222	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AVP—epilepsy syndrome	0.00021	0.000221	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADAM10—epilepsy syndrome	0.00021	0.00022	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GRM5—epilepsy syndrome	0.00021	0.00022	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CHRM3—epilepsy syndrome	0.00021	0.00022	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CASP2—epilepsy syndrome	0.00021	0.00022	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL2—epilepsy syndrome	0.000209	0.000219	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000206	0.000216	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AVP—epilepsy syndrome	0.000205	0.000216	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CHRM2—epilepsy syndrome	0.000202	0.000212	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000202	0.000212	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000202	0.000212	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000201	0.000211	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—S100B—epilepsy syndrome	0.000198	0.000208	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000197	0.000207	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CHRM2—epilepsy syndrome	0.000197	0.000207	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000197	0.000207	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CDC42—epilepsy syndrome	0.000197	0.000207	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SOCS3—epilepsy syndrome	0.000196	0.000206	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GABBR1—epilepsy syndrome	0.000196	0.000206	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CDC42—epilepsy syndrome	0.000196	0.000206	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CDC42—epilepsy syndrome	0.000193	0.000202	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	0.000192	0.000201	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	0.000191	0.0002	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AVP—epilepsy syndrome	0.00019	0.000199	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	0.000188	0.000197	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	0.000186	0.000196	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	0.000185	0.000194	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	0.000184	0.000193	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	0.000181	0.00019	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HES1—epilepsy syndrome	0.000179	0.000188	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000179	0.000188	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	0.000175	0.000184	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000175	0.000183	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000175	0.000183	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FYN—epilepsy syndrome	0.000174	0.000183	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—H2AFX—epilepsy syndrome	0.000174	0.000183	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MEF2C—epilepsy syndrome	0.000174	0.000182	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	0.000171	0.00018	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000171	0.000179	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	0.00017	0.000179	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	0.00017	0.000179	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000168	0.000176	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	0.000167	0.000175	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000167	0.000175	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NGF—epilepsy syndrome	0.000166	0.000174	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	0.000166	0.000174	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	0.000164	0.000173	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	0.000164	0.000173	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	0.000164	0.000173	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	0.000164	0.000173	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	0.000164	0.000173	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	0.000162	0.00017	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	0.000162	0.00017	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCR5—epilepsy syndrome	0.000161	0.000169	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	0.000161	0.000169	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	0.000161	0.000169	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	0.000161	0.000169	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	0.000161	0.000169	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	0.000161	0.000169	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000159	0.000167	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	0.000159	0.000167	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR2A—epilepsy syndrome	0.000158	0.000166	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000155	0.000163	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000153	0.000161	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	0.000153	0.00016	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	0.000153	0.00016	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	0.000151	0.000158	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TSC2—epilepsy syndrome	0.00015	0.000158	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.00015	0.000157	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AGT—epilepsy syndrome	0.00015	0.000157	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	0.000149	0.000157	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	0.000149	0.000157	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	0.000149	0.000156	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	0.000149	0.000156	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	0.000149	0.000156	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	0.000147	0.000155	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	0.000147	0.000155	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APOE—epilepsy syndrome	0.000147	0.000154	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000145	0.000153	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	0.000145	0.000153	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	0.000145	0.000153	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	0.000145	0.000153	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	0.000145	0.000152	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	0.000144	0.000151	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KDR—epilepsy syndrome	0.000144	0.000151	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000142	0.000149	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	0.000142	0.000149	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	0.00014	0.000147	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	0.00014	0.000147	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	0.00014	0.000147	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000139	0.000146	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000139	0.000145	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PRKCB—epilepsy syndrome	0.000138	0.000145	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6ST—epilepsy syndrome	0.000138	0.000145	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	0.000137	0.000144	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	0.000137	0.000144	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000137	0.000144	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	0.000137	0.000144	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	0.000137	0.000144	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	0.000136	0.000143	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000136	0.000143	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000136	0.000142	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	0.000134	0.000141	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	0.000134	0.000141	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	0.000134	0.000141	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	0.000134	0.00014	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	0.000131	0.000137	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	0.00013	0.000136	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	0.000127	0.000134	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	0.000127	0.000133	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	0.000127	0.000133	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—POMC—epilepsy syndrome	0.000126	0.000132	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	0.000125	0.000131	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	0.000125	0.000131	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	0.000124	0.00013	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	0.000124	0.00013	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL2—epilepsy syndrome	0.000123	0.00013	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	0.000122	0.000128	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	0.000121	0.000127	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	0.000118	0.000124	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	0.000117	0.000122	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	0.000116	0.000122	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	0.000115	0.000121	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	0.000114	0.00012	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	0.000114	0.00012	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	0.000113	0.000118	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FGF2—epilepsy syndrome	0.000112	0.000117	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	0.00011	0.000116	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	0.000107	0.000112	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	0.000104	0.000109	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	0.000104	0.000109	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RELA—epilepsy syndrome	0.000104	0.000109	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	0.000103	0.000108	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	0.000103	0.000108	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MTOR—epilepsy syndrome	0.000102	0.000107	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	0.000101	0.000106	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	0.000101	0.000106	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	0.000101	0.000106	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	9.96e-05	0.000105	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	9.84e-05	0.000103	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	9.74e-05	0.000102	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	9.63e-05	0.000101	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	9.58e-05	0.000101	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—AKT1—epilepsy syndrome	9.42e-05	9.9e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	9.37e-05	9.84e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	9.37e-05	9.84e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CASP3—epilepsy syndrome	9.34e-05	9.81e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	9.17e-05	9.63e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—JUN—epilepsy syndrome	9.07e-05	9.52e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	8.9e-05	9.35e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	8.89e-05	9.34e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MMP9—epilepsy syndrome	8.82e-05	9.27e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	8.71e-05	9.15e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	8.71e-05	9.15e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	8.7e-05	9.14e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—AKT1—epilepsy syndrome	8.56e-05	8.99e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	8.54e-05	8.97e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	8.52e-05	8.95e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	8.35e-05	8.77e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	8.22e-05	8.63e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	8.18e-05	8.6e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SRC—epilepsy syndrome	8.13e-05	8.54e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	8.04e-05	8.44e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	8e-05	8.41e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—VEGFA—epilepsy syndrome	7.92e-05	8.32e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	7.48e-05	7.86e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	7.32e-05	7.69e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	7.32e-05	7.69e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	7.16e-05	7.52e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	6.62e-05	6.95e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	6.47e-05	6.8e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	6.14e-05	6.45e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	6.02e-05	6.33e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	6.01e-05	6.31e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	5.89e-05	6.19e-05	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.59e-05	5.87e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	5.54e-05	5.82e-05	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	5.47e-05	5.75e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	5.42e-05	5.69e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	5.38e-05	5.65e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	5.27e-05	5.53e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	5.24e-05	5.5e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	5.12e-05	5.38e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	5.08e-05	5.33e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AKT1—epilepsy syndrome	5.05e-05	5.31e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	4.97e-05	5.22e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	4.83e-05	5.07e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	4.72e-05	4.96e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	4.7e-05	4.94e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	4.6e-05	4.83e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	3e-05	3.15e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	2.93e-05	3.08e-05	CbGpPWpGaD
